QA: Cartesian Therapeutics Inc. in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001453687_2021_Cartesian_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001453687, Cartesian Therapeutics Inc.

  xvar xval
0 AssetsCurrent 151,343,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,395,000
3 remainder_Assets 12,697,000
4 LiabilitiesCurrent 81,547,000
5 LiabilitiesNoncurrent 48,393,000
6 remainder_Liabilities 53,501,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 18,913,000
9 ResearchAndDevelopmentExpense 54,505,000
10 remainder_Expenses 11,999,000
11 remainder_Revenues 16,597,000
12 remainder_NetIncome -56,000
13 remainder_ComprehensiveNetIncome -40,000
  yvar yval
0 Assets 165,435,000
1 Liabilities 183,441,000
2 Expenses 85,417,000
3 Revenues 16,597,000
4 StockholdersEquity -18,006,000
5 NetIncome -68,876,000
6 ComprehensiveNetIncome -68,896,000
7 BaseVar 225,493,000
8 EconomicCapitalRatio -0.573

Edgar->Model Mapping

Feature Distribution

Change over Time